# PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers

> **NCT01287845** · PHASE1 · COMPLETED · sponsor: **Life Molecular Imaging SA** · enrollment: 14 (actual)

## Conditions studied

- Diagnostic Imaging

## Interventions

- **DRUG:** BAY1075553
- **DRUG:** BAY1075553

## Key facts

- **NCT ID:** NCT01287845
- **Lead sponsor:** Life Molecular Imaging SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01287845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01287845, "PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01287845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*